A panel on “Women’s Development to Women-led Development in S&T,” featuring Lt Gen Madhuri Kanitkar, Vibha Tandon, Bineesha Payattati, Tanushree Bhowmik and Manjusha Rajagopal, highlighted the need to ...
Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...
British journal Nature’s top 10 list gives credit to the man behind the widely acclaimed, Chinese-developed R1 reasoning AI ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
The answer is yes, absolutely, absolutely 100%. but it's not all kinds of math, and it's not all kinds of programming. that ...
Bedford ‘s Nicole Steele, a biochemistry and molecular biology major at Clark University, is part of a team working with the ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
Key opportunities in the market include leveraging CRISPR's precision for improved crop traits, meeting food security demands amid climate change, and sustainable agriculture trendsDublin, Dec. 09, ...
Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...
MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches across all sgRNA positions with near-zero ...
Mama Loves to Eat on MSN
Why tomatoes tasted better 50 years ago - and how science might fix it
Ever bite into a supermarket tomato and wonder where all the flavor went? You're not imagining things. That watery, cardboard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results